The COVID-19 pandemic highlighted the need for fast-produced and adaptable vaccines that could be equally distributed around the world. Developing an efficient mRNA vaccine that is effective, thermostable, and has fewer side effects strongly depends on lipid nanoparticles (LNPs) which preserve and deliver mRNA to cells. Lipid nanoparticles appear to be the sole solution to global health issues, and that is why well-known biopharma companies and startups are currently focusing exactly on this.
It might sound easy, but it is not. COVID-19 mRNA vaccines widely used worldwide, such as Comirnaty by Pfizer/BioNTech and Spikevax by Moderna, are proven effective and safe. There are, however, some downsides to current mRNA technologies.
Another issue with today’s COVID-19 mRNA vaccines are the common side effects such as inflammation, fever, and aches. These side effects are caused by lipids which are not fully biodegradable, therefore not disintegrating completely in the body after their work is done. The other challenge of the LNP development is the constant need to adapt to new variants while entrapping bigger payloads to be more efficient.
What can be done to advance LNP technology and the future of mRNA vaccines? As a matter of fact, a lot of scientists are already working on this innovation.
AexeRNA Therapeutics, co-founded by Dr. Drew Weissman, whose research paved the way for the mRNA vaccines, has a proprietary ionizable lipid library. This gives the ability to quickly select the optimal lipids for immunization or therapeutic application. It means that the technology can become more rapidly adjustable to the new variants or applied to other diseases.
The company’s research exemplifies some promising results in mRNA delivery efficiency with controlled distribution to various organs. AexeRNA’s LNP platform is also addressing side effects by lowering toxicity of the system. Their research is dealing with logistics issues by making the vaccine easier to store and transport.
Dr. Pieter Cullis, another world-renowned scientist, has been working on LNP technology for decades. He co-founded and served on the board of more than ten companies, one of which is NanoVation Therapeutics. This company focuses on personalized gene therapeutics. Their pre-clinical studies are focused on the efficacy and biodistribution of LNPs making their research valuable for developing mRNA vaccines.
The other company co-founded by Cullis and led by Dr. Thomas Madden, Acuitas Therapeutics, has an agreement with Pfizer/BioNTech to use its proprietary lipid nanoparticle technology in the development of COVID-19 vaccines. Moreover, the same LNP components can be used in different mRNA vaccines, simplifying their creation for future variants and other diseases.
Last but not least is the revolutionary biopharma startup NeoVac. Using novel lipid nanoparticle technology developed by the company’s co-founder Professor Dan Peer at his Lab at Tel Aviv University, the company aims to overcome existing challenges with the LNPs technology. NeoVac’s in-vivo studies showed fewer side effects due to the fully biodegradable lipids that compose the LNPs. NeoVac’s LNPs have no effect on the liver in fatty liver disease as compared to significant damage by some other vaccines. In addition, their delivery system entraps triple the currently available RNA load and can address multiple variants with multiple payloads simultaneously. This results in higher effectiveness without increasing the dose.
mRNA has proven effective during pandemics and is promising in preventing and treating many other diseases, including cancer. The development of LNPs is crucial for the success of mRNA technologies. The future of global health is in the hands of biopharma companies that are on their way to creating mRNA vaccines with a lower cost of storage and transportation, fewer adverse effects, and faster response to the new variants.
News
AI therapy may help with mental health, but innovation should never outpace ethics
Mental health services around the world are stretched thinner than ever. Long wait times, barriers to accessing care and rising rates of depression and anxiety have made it harder for people to get timely help. As a result, governments and health care providers are [...]
Global life expectancy plunges as WHO warns of deepening health crisis Post-COVID
The World Health Organization (WHO) has sounded the alarm on the long-term health repercussions of the COVID-19 pandemic in its newly released World Health Statistics Report 2025. The report reveals a staggering decline in global [...]
Researchers map brain networks involved in word retrieval
How are we able to recall a word we want to say? This basic ability, called word retrieval, is often compromised in patients with brain damage. Interestingly, many patients who can name words they [...]
Melting Ice Is Changing the Color of the Ocean – Scientists Are Alarmed
Melting sea ice changes not only how much light enters the ocean, but also its color, disrupting marine photosynthesis and altering Arctic ecosystems in subtle but profound ways. As global warming causes sea ice in the [...]
Your Washing Machine Might Be Helping Antibiotic-Resistant Bacteria Spread
A new study reveals that biofilms in washing machines may contain potential pathogens and antibiotic resistance genes, posing possible risks for laundering healthcare workers’ uniforms at home. Washing healthcare uniforms at home could be [...]
Scientists Discover Hidden Cause of Alzheimer’s Hiding in Plain Sight
Researchers found the PHGDH gene directly causes Alzheimer’s and discovered a drug-like molecule, NCT-503, that may help treat the disease early by targeting the gene’s hidden function. A recent study has revealed that a gene previously [...]
How Brain Cells Talk: Inside the Complex Language of the Human Mind
Introduction The human brain contains nearly 86 billion neurons, constantly exchanging messages like an immense social media network, but neurons do not work alone – glial cells, neurotransmitters, receptors, and other molecules form a vast [...]
Oxford study reveals how COVID-19 vaccines prevent severe illness
A landmark study by scientists at the University of Oxford, has unveiled crucial insights into the way that COVID-19 vaccines mitigate severe illness in those who have been vaccinated. Despite the global success of [...]
Annual blood test could detect cancer earlier and save lives
A single blood test, designed to pick up chemical signals indicative of the presence of many different types of cancer, could potentially thwart progression to advanced disease while the malignancy is still at an early [...]
How the FDA opens the door to risky chemicals in America’s food supply
Lining the shelves of American supermarkets are food products with chemicals linked to health concerns. To a great extent, the FDA allows food companies to determine for themselves whether their ingredients and additives are [...]
Superbug crisis could get worse, killing nearly 40 million people by 2050
The number of lives lost around the world due to infections that are resistant to the medications intended to treat them could increase nearly 70% by 2050, a new study projects, further showing the [...]
How Can Nanomaterials Be Programmed for Different Applications?
Nanomaterials are no longer just small—they are becoming smart. Across fields like medicine, electronics, energy, and materials science, researchers are now programming nanomaterials to behave in intentional, responsive ways. These advanced materials are designed [...]
Microplastics Are Invading Our Arteries, and It Could Be Increasing Your Risk of Stroke
Higher levels of micronanoplastics were found in carotid artery plaque, especially in people with stroke symptoms, suggesting a potential new risk factor. People with plaque buildup in the arteries of their neck have been [...]
Gene-editing therapy shows early success in fighting advanced gastrointestinal cancers
Researchers at the University of Minnesota have completed a first-in-human clinical trial testing a CRISPR/Cas9 gene-editing technique to help the immune system fight advanced gastrointestinal (GI) cancers. The results, recently published in The Lancet Oncology, show encouraging [...]
Engineered extracellular vesicles facilitate delivery of advanced medicines
Graphic abstract of the development of VEDIC and VFIC systems for high efficiency intracellular protein delivery in vitro and in vivo. Credit: Nature Communications (2025). DOI: 10.1038/s41467-025-59377-y. https://www.nature.com/articles/s41467-025-59377-y Researchers at Karolinska Institutet have developed a technique [...]
Brain-computer interface allows paralyzed users to customize their sense of touch
University of Pittsburgh School of Medicine scientists are one step closer to developing a brain-computer interface, or BCI, that allows people with tetraplegia to restore their lost sense of touch. While exploring a digitally [...]
